FIELD: medicinal chemistry.
SUBSTANCE: invention is related to derivatives of 2-((1-(4-benzyl)-1H-1,2,3-triazol-4-yl)methoxy)-3-methyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-ol of formula 1, where R can be a hydrogen atom, a methyl group or a trifluoromethyl group.
EFFECT: compounds of formula 1 that have antiparkinsonian activity.
1 cl, 2 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 2-((1H-1,2,4-TRIAZO-3-YL)THIO)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1-OL AS AN ANTIPARKINSONIAN AGENT | 2022 |
|
RU2796729C1 |
| 3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1,2-DIOL- EPOXIDES - NEW ANTIPARKINSONIAN DRUGS AND ANTI-CONVULSANTS | 2014 |
|
RU2571299C1 |
| 1-(4-ISOXAZOLE-5-YL)-1H-PYRAZOLE-1-YL)-2-METHYLPROPANE-2-OL DERIVATIVES AND RELATED COMPOUNDS AS IL-17 AND IFN-GAMMA INHIBITORS FOR TREATMENT OF AUTOIMMUNE DISEASES AND CHRONIC INFLAMMATION | 2018 |
|
RU2785342C2 |
| METHODS OF PRODUCING SOME 2-(PYRIDIN-3-YL)THIAZOLES | 2013 |
|
RU2647851C2 |
| INHIBITORS OF HUMAN POLY(ADP-RIBOSO)POLYMERASE-1 BASED ON URACYL DERIVATIVES | 2012 |
|
RU2527457C2 |
| METHOD FOR SYNTHESIS OF (Z)-3-(2-BUTOXY-3'-(3-HEPTYL-1-METHYLUREIDO) BIPHENYL-4-YL)-2-METHOXYACRYLIC ACID | 2008 |
|
RU2478614C2 |
| 1-ARYLPYRROLO[1,2A]PYRAZINE-3-CARBOXAMIDES WITH NEUROPSYCHOTROPIC ACTIVITY | 2014 |
|
RU2572076C2 |
| (6S,9AS)-N-BENZYL-6-[(4-HYDROXYPHENYL)METHYL]-4,7-DIOXO-8-({6-[3-(PIPERAZIN-1-YL)AZETHYDIN-1-YL]PYRIDINE-2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRASINO[2,1-C][1,2,4]TRIAZINE-1-CARBOXAMIDE COMPOUND | 2014 |
|
RU2669805C2 |
| METHODS FOR PRODUCING CERTAIN 2-(PYRIDINE-3-YL)THIAZOLES | 2013 |
|
RU2647853C2 |
| PYRAZOLE COMPOUNDS AS SIGMA RECEPTOR INHIBITORS | 2011 |
|
RU2582338C2 |
